ACOG · Alpha Cognition Inc. · Webcasts, Transcripts & Audio
Market Cap
$186.20M
Shares
21.78M
Volume · Oct 5
52.6K
Avg daily vol (3M)
125K
Alpha Cognition Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Alpha Cognition Inc. (ACOG), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q1
2026-03-31
Alpha Cognition Inc. (ACOG) Q1 2026 Earnings Call Transcript
Confident tone
ZUNVEYL Commercial Launch
Clinical / Real-World Evidence Programs
Prescriber & Sales Force Growth
Revenue
$3.53M
▲ 20.7% YoY Diluted EPS
$-0.32
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Alpha Cognition Inc. (ACOG) Q4 2025 Earnings Call Transcript
Confident tone
ZUNVEYL commercial launch and revenue growth
Real-world evidence studies (BEACON, CONVERGE, RESOLVE)
Long-term care adoption and prescriber expansion
Revenue
$2.79M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Alpha Cognition Inc. (ACOG) Q3 2025 Earnings Call Transcript
Confident tone
ZUNVEYL commercial launch metrics
International expansion via CMS Pharma in China
Pricing and gross-to-net
Revenue
$2.84M
▼ 97.2% YoY Diluted EPS
$-0.30
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Alpha Cognition Inc. (ACOG) Q2 2025 Earnings Call Transcript
Confident tone
ZUNVEYL commercial launch
Sublingual formulation R&D
Healthcare professional engagement
Revenue
$1.66M
▼ 98.3% YoY Diluted EPS
$-0.82
Gross margin
87.7%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Alpha Cognition Inc. (ACOG) Q1 2025 Earnings Call Transcript
Confident tone
ZUNVEYL commercial launch
Medicare reimbursement and access
Intellectual property and patents
Revenue
$2.93M
Diluted EPS
$-0.11
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 webcasts